Sign in >>

News item: Nomir announces data from Noveon Laser pivotal trial on onychomycosis

Nomir Medical Technologies, Inc., a leader in novel photobiology and laser therapies, announced today that new data from its landmark pivotal onychomycosis trial first published in the peer-reviewed Journal of the American Podiatric Medical Association (JAPMA) has once again been published in this prestigious journal. The new paper, which reports on a 270 day onychomycosis clinical trial, offers …

Posted about 2 years ago

Continue reading...

Back to news index



Send feedback about this page
Email a link to this page

This topic elsewhere

Loading...
Loading...